Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2024-209513

Published: 2024

Journal Articles

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Blood (2024) 144 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2024-211584

Published: 2024

Journal Articles

Multi-Center Analysis of Clinical Characteristics, Outcomes and Overall Survival of an Under-Studied Entity: Paroxysmal Nocturnal Hemoglobinuria Associated with Bone Marrow Disorder

Laura Guadalupe Ceja Ramirez, Abigail Daniela Vieyra, Jose Alvarez, Roberta Demichelis, Martha Alvarado, Moises Xololt, Antonio De La Peña, Juan Manuel Perez, Luara Arana, Elia Ixel Apodaca

Blood (2022) 140 (Supplement 1): 8656–8657.

https://doi.org/10.1182/blood-2022-170818

Published: 2022

Journal Articles

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Perla R.R. Colunga-Pedraza, Andres Gomez-De Leon, Christianne Bourlon De Los Rios, Cesar Omar Vargas-Serafin, Myrna Patricia Pequeño Luevano, Lauro Fabian Amador, Carolina García-Castillo, Martha Alvarado, Guillermo José Ruiz-Argüelles, Alberto Olaya-Vargas, Samantha P. Peña-Lozano, Guadalupe González Villarreal, Elías Eugenio González López, Gabriela Cardoso Yah, Ivan Murrieta-Alvarez, Luis Mario Villela Martinez, David Gomez Almaguer

Blood (2022) 140 (Supplement 1): 5185–5187.

https://doi.org/10.1182/blood-2022-169096

Published: 2022

Journal Articles

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-142823

Published: 2020

Journal Articles

Azacitidine Maintenance Versus No Maintenance after Standard Therapy in Patientswith Acute Myeloid Leukemia, a Mexican Center Experience

Antonio De La Peña, MD, Denisse J. Fermin-Caminero, MD, Oscar Teomitzi-Sanchez, MD, Luara Arana, Jose Alvarez, MDDHSC,BA,BMBS,BSc, Juan Manuel Perez, María Eugenia Espitia, Eleazar Hernandez, MD, Martha Alvarado

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-142855

Published: 2020

Journal Articles

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139018

Published: 2020

Journal Articles

Conditioning Chemotherapy with BOR-MEL in Autologous Stem Cell Transplant in Multiple Myeloma

Jose L Alvarez, Sr., MD, M. Augusta Pacheco, MD, Pedro Guzman, MD, Leire Montoya, MD, Veronica MENA, MD, Maricela Ortiz, MD, Rosa Jimenez, MD, Martha Alvarado, MD

Blood (2017) 130 (Supplement 1): 5531.

https://doi.org/10.1182/blood.V130.Suppl_1.5531.5531

Published: 2017

Journal Articles

Ten Years of Experience in the Non-Intensive Treatment of Acute Leukemias in Elderly Patients of the Hematology Service of the National Medical Center November 20, ISSSTE

Jose L Alvarez, Sr., MD, Yayra Pichardo, MD, Maricela Ortiz, MD, Veronica MENA, MD, Rosa Jimenez, MD, Luara Arana, MD, M. Augusta Pacheco, MD, Martha Alvarado, MD

Blood (2017) 130 (Supplement 1): 5053.

https://doi.org/10.1182/blood.V130.Suppl_1.5053.5053

Published: 2017

Journal Articles

Long Term Results of Patients with Acute Promyelocytic Leukemia of Recent Diagnosis Treated with Daunorubicin or Epirubicin in Induction Therapy

Luara Arana, MD, Jose Alvarez, MDDHSC,BA,BMBS,BSc, Martha Alvarado, MD, Yayra Pichardo, MD, M. Augusta Pacheco, MD, Veronica MENA, MD, Maricela Ortiz, MD, Rosa Jimenez, MD

Blood (2017) 130 (Supplement 1): 5024.

https://doi.org/10.1182/blood.V130.Suppl_1.5024.5024

Published: 2017

Journal Articles

Tinidazole As Prophylaxis of Amoebic Colitis in Patients with Acute Leukemia of Recent Diagnosis during Induction Chemotherapy

Luara Arana, MD, Martha Alvarado, MD, Manuel Lopez, MD, M. Augusta Pacheco, MD

Blood (2017) 130 (Supplement 1): 5030.

https://doi.org/10.1182/blood.V130.Suppl_1.5030.5030

Published: 2017

Journal Articles

Screening for Retrovirus Genomes in Childhood Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 4301.

https://doi.org/10.1182/blood.V120.21.4301.4301

Published: 2012

Journal Articles

Compassionate Use Program (CUP) with Ruxolitinib in Mexican Patients with Primary Myelofibrosis (PMF), Post – Polycythemia, Vera Myelofibrosis (PPV – MF), and Post–Essential Thrombocythemia Myelofibrosis (PET – MF)

Pablo Vargas, MD, Roberto Ovilla, MD, Martha Alvarado, MD, Manuel Lopez, MD, Rafael Hurtado Monroy, MD., Juan_Carlos Solis, MD, Alejandro Limon, MD, Gladys Agreda, MD, Salvador Silva, MD, Juan Julio Kassack, MD, Saida Zavala, MD, Carlos Aguilar, MD, Enrique Baez, Esperanza Barrera, MD, Antonio Osuna, MD, Javier Morales, MD, Aquileo Herrera, MD

Blood (2012) 120 (21): 5067.

https://doi.org/10.1182/blood.V120.21.5067.5067

Published: 2012

Journal Articles

Nilotinib (AMN107) Can Induce Complete Cytogenetic Responses (CCyR) and Molecular Responses in Patients (Pts) with Advanced Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib Mesylate (IM). Report of the Compassionate Use Program of Nilotinib in Mexico

Blood (2008) 112 (11): 4275.

https://doi.org/10.1182/blood.V112.11.4275.4275

Published: 2008

Journal Articles

Compassionate Use of Nilotinib (AMN107) in Mexican Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib.

Manuel Ayala, MD, Rafael Hurtado, MD, Kevin Nacho, MD, Norma Tapia, MD, Martha Alvarado, MD, Alvaro Aguayo, MD, Sergio Cleto, MD, Yolanda Lugo, MD, Gustavo Reyes, MD, Pablo Vargas, MD, Angel Herrera, Luis Antonio Meillon, MD

Blood (2007) 110 (11): 4578.

https://doi.org/10.1182/blood.V110.11.4578.4578

Published: 2007

Journal Articles

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Jose R. Borbolla Escoboza, MD, Manuel A. Lopez-Hernandez, MD, Marcos E. Garza, MD, Enrique Baez, MD, Elvira Trueba, MD, Roberto Hernandez, MD, Jose E. DeDiego-FloresChapa, MD, Severiano Baltazar, MD, Martha Alvarado, MD, Gerardo Villareal, MD, Mauricio C. Gonzalez-Avante, MD, Rosa E. De Leon, MD, Jose L. Cedillo, MD, Jason A. Penniecook, MD, Yara E. Tovar, MD, Maria I. Leon, Cecilia Ramirez-Assad, MD

Blood (2004) 104 (11): 5015.

https://doi.org/10.1182/blood.V104.11.5015.5015

Published: 2004

Journal Articles

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Blood (2004) 104 (11): 4312.

https://doi.org/10.1182/blood.V104.11.4312.4312

Published: 2004

NARROW

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Using Polatuzumab Plus Chemotherapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real-World Study from the Grupo De Estudio De Linfoproliferativos De Latinoamerica (GELL)

Multi-Center Analysis of Clinical Characteristics, Outcomes and Overall Survival of an Under-Studied Entity: Paroxysmal Nocturnal Hemoglobinuria Associated with Bone Marrow Disorder

Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Azacitidine Maintenance Versus No Maintenance after Standard Therapy in Patientswith Acute Myeloid Leukemia, a Mexican Center Experience

Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry

Conditioning Chemotherapy with BOR-MEL in Autologous Stem Cell Transplant in Multiple Myeloma

Ten Years of Experience in the Non-Intensive Treatment of Acute Leukemias in Elderly Patients of the Hematology Service of the National Medical Center November 20, ISSSTE

Long Term Results of Patients with Acute Promyelocytic Leukemia of Recent Diagnosis Treated with Daunorubicin or Epirubicin in Induction Therapy

Tinidazole As Prophylaxis of Amoebic Colitis in Patients with Acute Leukemia of Recent Diagnosis during Induction Chemotherapy

Screening for Retrovirus Genomes in Childhood Acute Lymphoblastic Leukemia

Compassionate Use Program (CUP) with Ruxolitinib in Mexican Patients with Primary Myelofibrosis (PMF), Post – Polycythemia, Vera Myelofibrosis (PPV – MF), and Post–Essential Thrombocythemia Myelofibrosis (PET – MF)

Nilotinib (AMN107) Can Induce Complete Cytogenetic Responses (CCyR) and Molecular Responses in Patients (Pts) with Advanced Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib Mesylate (IM). Report of the Compassionate Use Program of Nilotinib in Mexico

Compassionate Use of Nilotinib (AMN107) in Mexican Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib.

Clinical Results of a −80°C Simplified Cryo-Preservation Method.

Frequency of Genetic Deletions of the Glutathione-S Transferase (Gst) Gene in Mexican Patients with De Novo Acute Leukemia: A Preliminary Report from the “Instituto Tecnologico De Monterrey-Hematology Research Group”.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only